Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone safety in pediatric functional constipation
NCT02766777Phase 3Completed
- Sponsor
- Sucampo
- Start
- Apr 2016
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cobiprostone in functional constipation (FC), sponsored by Sucampo. Primary endpoint: Number of Participants With at Least One Treatment-emergent Adverse Event at 25 weeks. Started Apr 2016; status: completed.
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT02766777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02766777.